Literature DB >> 25637312

Neural mechanism underlying hyperalgesic response to orofacial pain in Parkinson's disease model rats.

Hiroharu Maegawa1, Yoshinari Morimoto2, Chiho Kudo3, Hiroshi Hanamoto3, Aiji Boku3, Mitsutaka Sugimura3, Takafumi Kato4, Atsushi Yoshida4, Hitoshi Niwa3.   

Abstract

To investigate the neural mechanism of pain originating from the orofacial region in PD patients, we used PD model rats produced by unilateral injection of 6-hydroxydopamine (6-OHDA) into the medial forebrain bundle. We investigated effects of nigrostriatal lesions on the behavioral response (face rubbing) to formalin injection into the upper lip. We also examined expression of c-Fos and phosphorylated extracellular signal-regulated kinase (pERK) in the trigeminal spinal subnucleus caudalis (Vc) and expression of c-Fos in the periaqueductal gray matter (PAG). Face rubbings following formalin injection showed a biphasic profile, with the first phase for the first 5 min and the second phase from 10 to 90 min. Rats with 6-OHDA lesions showed increased face rubbings in the second phase when formalin was injected ipsilaterally to the lesion, and c-Fos expression in the Vc increased. When formalin was injected contralaterally, face rubbings were reduced in the first phase, however, expression levels of c-Fos and pERK in the Vc were unchanged. No significant difference was found in c-Fos expression in the PAG between 6-OHDA- and saline-injected rats. These results suggest that unilateral dopamine depletion in the nigrostriatal pathway may be involved in hypersensitivity to noxious stimulation delivered to the orofacial region.
Copyright © 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.

Entities:  

Keywords:  6-Hydroxydopamine; Formalin; Medial forebrain bundle; Parkinson's disease; Periaqueductal gray matter; Trigeminal spinal subnucleus caudalis; Tyrosine hydroxylase; c-Fos

Mesh:

Substances:

Year:  2015        PMID: 25637312     DOI: 10.1016/j.neures.2015.01.006

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  8 in total

Review 1.  Potential of animal models for advancing the understanding and treatment of pain in Parkinson's disease.

Authors:  Yazead Buhidma; Katarina Rukavina; Kallol Ray Chaudhuri; Susan Duty
Journal:  NPJ Parkinsons Dis       Date:  2020-01-06

2.  Generation of Mitochondrial Toxin Rodent Models of Parkinson's Disease Using 6-OHDA , MPTP , and Rotenone.

Authors:  Hiroharu Maegawa; Hitoshi Niwa
Journal:  Methods Mol Biol       Date:  2021

3.  Inhibition of NADPH oxidase within midbrain periaqueductal gray decreases pain sensitivity in Parkinson's disease via GABAergic signaling pathway.

Authors:  W Zhang; L Sun; X Yang; R Wang; H Wang
Journal:  Physiol Res       Date:  2020-06-25       Impact factor: 1.881

Review 4.  Potential of animal models for advancing the understanding and treatment of pain in Parkinson's disease.

Authors:  Yazead Buhidma; Katarina Rukavina; Kallol Ray Chaudhuri; Susan Duty
Journal:  NPJ Parkinsons Dis       Date:  2020-01-06

5.  Bilateral Parkinson's disease model rats exhibit hyperalgesia to subcutaneous formalin administration into the vibrissa pad.

Authors:  Hiroharu Maegawa; Nayuka Adachi; Hiroshi Hanamoto; Chiho Kudo; Hitoshi Niwa
Journal:  PLoS One       Date:  2019-12-05       Impact factor: 3.240

6.  α-Pinene Influence on Pulpal Pain-Induced Learning and Memory Impairment in Rats Via Modulation of the GABAA Receptor.

Authors:  Forouzan Rafie; Razieh Kooshki; Mehdi Abbasnejad; Iran Rahbar; Maryam Raoof; Amir Hossein Nekouei
Journal:  Adv Biomed Res       Date:  2022-07-29

7.  Contribution of Pro-inflammatory Cytokine Signaling within Midbrain Periaqueductal Gray to Pain Sensitivity in Parkinson's Disease via GABAergic Pathway.

Authors:  Xianbo Zhuang; Yanxiu Chen; Xianpeng Zhuang; Tuanzhi Chen; Tao Xing; Weifei Wang; Xiafeng Yang
Journal:  Front Neurol       Date:  2016-07-25       Impact factor: 4.003

8.  The Cataleptic, Asymmetric, Analgesic, and Brain Biochemical Effects of Parkinson's Disease Can Be Affected by Toxoplasma gondii Infection.

Authors:  Mahnaz Taherianfard; Moslem Riyahi; Mostafa Razavi; Zahedeh Bavandi; Narges Eskandari Roozbahani; Mohammad Mehdi Namavari
Journal:  Biomed Res Int       Date:  2020-05-01       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.